With AI and high-tech industries dominating China’s plans for future growth, it comes as no surprise that related sectors have seen a huge influx of capital in recent years. But with special…
By Jihuan (Henry) Liang, Jinlong (Eason) Wan, and Linyu Wang We see three macro trends. First, on the industrial level, the growth rate of the financial industry has slowed down. McKinsey’s Global…
With COVID-19 disrupting every aspect of life, it’s more important than ever to keep potential outbreaks under control, help economies recover as quickly as possible, support the roll-out of vaccines, and safely…
With the development of COVID-19 vaccines, the Chinese government is adopting measures to ensure that employers are providing vaccination plans to their employees, an important step to ensure a successful fight against…
This article is from the AmCham China Quarterly Magazine. To access the entire publication for free, sign up on our member portal here.
In the latest in our series profiling current Board members, Alain Benichou discusses his role within the AmCham China community – both in his native France as well as in China –…
China’s annual meetings of the National People’s Congress (NPC) and Chinese People’s Political Consultative Conference (CPPCC) – collectively known as the Two Sessions – convened this year in an atmosphere of guarded…
AmCham China sat down with Will Song, Global Senior Vice President and China Chairman for Johnson & Johnson, to reflect on the last year, take stock of the company’s strategies and priorities…
Pierre Gaudreault is China Regional President for Pfizer Biopharmaceuticals Group. He is a well-respected corporate executive and thought leader in the pharmaceutical industry, and a highly experienced professional with more than 25…